Interactions of catecholamines and adrenergic blocking agents at receptor sites mediating glycogenolysis in the rat.
D000818:Animals; D004147:Dioxins / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology*; D004878:Ergotamine / Q000494:pharmacology; D005260:Female; D006003:Glycogen / Q000378:metabolism*; D006321:Heart / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008112:Liver Glycogen / Q000378:metabolism; D009132:Muscles / Q000187:drug effects / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D010646:Phentolamine / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug; D013565:Sympatholytics / Q000494:pharmacology*; D013997:Time Factors
D004147:Dioxins; D008112:Liver Glycogen; D010879:Piperazines; D011955:Receptors, Drug; D013565:Sympatholytics; D006003:Glycogen; D007545:Isoproterenol; D004878:Ergotamine; D004837:Epinephrine; D010646:Phentolamine